FOR IMMEDIATE RELEASE
The first and only guaranteed ultrasound repair solution makes efficient use of shrinking healthcare budgets
WARRENDALE, Pa., March 19, 2009 – MEDRAD, INC., Multi Vendor Service has announced the launch of TotalRepair, the first and only guaranteed repair solution on select ultrasound probes. Enabled by 100 percent repair capabilities, TotalRepair allows healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.
“MVS is committed to developing new repair techniques that will make equipment service budgets go farther. This has immense value to healthcare systems during grueling economic times like these,” said Diane Watson, executive director of MEDRAD Multi Vendor Service. “With our ever-increasing repair capabilities and new offerings like TotalRepair, MVS can help hospitals and imaging centers save money by extending the life of their equipment.”
TotalRepair not only helps healthcare facilities reduce service costs, but also mitigate overall financial exposure with a capped, guaranteed “worst case scenario” price provided up front. MVS supports its repair guarantee on eligible probes with an extended six-month warranty.*
For a complete listing of probes that are eligible for TotalRepair, please contact MVS Customer Care at 800-MEDRAD-1 x5100 or mvscustomercare@medrad.com.
*Extended six-month warranty applies only to MVS-applied service on standard probes. Transesophageal (TEE) probes are covered under a 90-day warranty.
About MEDRAD Multi Vendor Service
Multi Vendor Service, as a part of the MEDRAD Service business, provides third-party service on ultrasound transducers, parts, MRI coils and imaging product services. With the highest repair rates, superior quality and customer care, MVS provides the best value in third-party service and supports it with more than 200 field-based personnel. For more information about MEDRAD MVS, visit the MVS section of our website.
About MEDRAD
MEDRAD, INC., is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD’s product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2007 revenues were $525 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company’s world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG.
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.
Cautionary statement regarding forward-looking statements.
Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC., undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.
###